Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Gross Profit: 2020-2024

Historic Gross Profit for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to $10.6 million.

  • Janux Therapeutics' Gross Profit rose 2177.90% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 57.77%. This contributed to the annual value of $10.6 million for FY2024, which is 30.99% up from last year.
  • Latest data reveals that Janux Therapeutics reported Gross Profit of $10.6 million as of FY2024, which was up 30.99% from $8.1 million recorded in FY2023.
  • Over the past 5 years, Janux Therapeutics' Gross Profit peaked at $10.6 million during FY2024, and registered a low of -$206,000 during FY2020.
  • In the last 3 years, Janux Therapeutics' Gross Profit had a median value of $8.6 million in 2022 and averaged $9.1 million.
  • As far as peak fluctuations go, Janux Therapeutics' Gross Profit surged by 1,865.53% in 2021, and later decreased by 6.14% in 2023.
  • Over the past 5 years, Janux Therapeutics' Gross Profit (Yearly) stood at -$206,000 in 2020, then surged by 1,865.53% to $3.6 million in 2021, then spiked by 136.79% to $8.6 million in 2022, then decreased by 6.14% to $8.1 million in 2023, then soared by 30.99% to $10.6 million in 2024.